325 Capital LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), 325 Capital LLC reported 12 stock positions worth $258.7 million. Its top holding was American Public Education (APEI) at 18.9% of the portfolio, followed by Blue Bird (BLBD, 12.1%) and Biote Class A (BTMD, 10.9%). Compared with Q3 2024, it opened 1 new position and added to 2. The biggest buy was a new position in Powerfleet (AIOT).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001873893
- Portfolio Value
- $258.7M (Q4 2024)
- SEC Filing
- 0001214659-25-002821 ↗ filed Feb 14, 2025
Holdings Value
Holdings 12 stocks · $258.7M
| APEI American Public Education | 18.93% | 2,270,108 | $49.0M | No change |
| BLBD Blue Bird Corp. | 12.12% | 811,757 | $31.4M | No change |
| BTMD Biote Corp. Class A | 10.87% | 4,548,127 | $28.1M | No change |
| ASTH Astrana Health Inc. | 10.81% | 886,916 | $28.0M | Add +30.3% |
| ATRO Astronics Corp. | 10.74% | 1,741,010 | $27.8M | No change |
| AIOT Powerfleet Inc. | 9.56% | 3,714,285 | $24.7M | New |
| MULTISENSOR AI HOLDINGS INC | 6.67% | 9,375,000 | $17.3M | No change |
| LFCR Lifecore Biomedical Inc. | 6.21% | 2,162,466 | $16.1M | Add +57.9% |
| MPAA Motorcar Parts of America Inc. | 5.93% | 2,018,795 | $15.3M | No change |
| HTLD Heartland Express Inc. | 4.92% | 1,135,015 | $12.7M | No change |
| SGOV iShares 0-3 Month Treasury B | 1.64% | 42,184 | $4.2M | No change |
| TACT Transact Technologies Inc. | 1.60% | 1,011,789 | $4.1M | No change |
Portfolio Sells Q3 2024 → Q4 2024
| None this quarter. | |||
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $419.5M | ASTH, MGNI, APEI, BLBD, SPIR |
| Q1 2026 | 12 | $274.5M | APEI, ASTH, BLBD, MGNI, SPIR |
| Q4 2025 | 13 | $285.4M | APEI, ASTH, MGNI, BLBD, MPAA |
| Q3 2025 | 12 | $329.1M | ATRO, APEI, BLBD, ASTH, MPAA |
| Q2 2025 | 11 | $253.3M | APEI, ATRO, BLBD, MPAA, SPIR |
| Q1 2025 | 11 | $241.4M | APEI, ATRO, ASTH, BLBD, AIOT |
| Q4 2024 | 12 | $258.7M | APEI, BLBD, BTMD, ASTH, ATRO |
| Q3 2024 | 11 | $236.2M | ASTH, BLBD, ATRO, APEI, BTMD |
| Q2 2024 | 13 | $238.1M | BLBD, ATRO, BTMD, ASTH, APEI |
| Q1 2024 | 12 | $216.6M | BLBD, ATRO, SGOV, ASTH, BTMD |